SPIN is a network open to partnerships with pharmaceutical industries for specific and occasional educational and research actions, such as studies, surveys, symposia and congresses, and other collaborative projects. You can check our partnership opportunities here. Each project will be clearly associated with the image of the partner industry. Its propositions shall be submitted to the SPIN Committee for approval.
Here below you will find some past examples of partnerships between a pharmaceutical industry and SPIN:
- Development of the regional psoriasis network Pso Maghreb, with Leo Pharma
- Triennial Congress (PSO 2010, PS0 2013, PSO 2016): Abbott/Abbvie, Almirall, Celgene, Genevrier/Ibsa, Janssen-Cilag, Lilly, MSD, Novartis, Sandoz Biopharmaceuticals,Schering Plough and Pfizer.
- PIN Symposium at the 1st and 2nd Latin American Congress of Psoriasis, with Leo Pharma
- PIN Symposium at the 13th Pan Arab League of Dermatology Conference on Saturday, 23rd February 2013 (2pm-4pm), with Leo Pharma